These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 122802)
1. Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin. Johnston TP; McCaleb GS; Montgomery JA J Med Chem; 1975 Jan; 18(1):104-6. PubMed ID: 122802 [No Abstract] [Full Text] [Related]
2. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity. Fox PA; Panasci LC; Schein PS Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478 [TBL] [Abstract][Full Text] [Related]
3. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity. Anderson T; McMenamin MG; Schein PS Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170 [TBL] [Abstract][Full Text] [Related]
4. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice. Panasci LC; Green D; Schein PS J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033 [TBL] [Abstract][Full Text] [Related]
5. New streptozotocin analogs with improved antileukemic activity. Fujiwara AN; Acton EM; Henry DW J Med Chem; 1974 Apr; 17(4):392-6. PubMed ID: 4275387 [No Abstract] [Full Text] [Related]
7. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent. Schein PS; Panasci L; Woolley PV; Anderson T Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756 [TBL] [Abstract][Full Text] [Related]
8. Alkyl streptozotocin analogues with improved biological activities. Iwasaki M; Ueno M; Ninomiya K; Sekine J; Nagamatsu Y J Med Chem; 1976 Jul; 19(7):918-23. PubMed ID: 133244 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose. Nagourney RA; Fox P; Schein PS Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314 [TBL] [Abstract][Full Text] [Related]
10. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity. Macdonald JS; Hoth D; Schein PS Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state. Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P Oncology; 1985; 42(2):122-8. PubMed ID: 3157909 [TBL] [Abstract][Full Text] [Related]
12. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems. Johnston TP; Montgomery JA Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250 [No Abstract] [Full Text] [Related]
13. Effects of N,N'-bis(2-chloroethyl)-N-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranose upon the proliferation, DNA synthesis, and viability of cultured sensitive and resistant L1210 cells. Wheeler GP; Alexander JA; Adamson DJ Cancer Res; 1980 Oct; 40(10):3723-7. PubMed ID: 6449283 [TBL] [Abstract][Full Text] [Related]
14. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level. Weinkam RJ; Dolan ME J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795 [TBL] [Abstract][Full Text] [Related]
15. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice. Panasci LC; Green D; Nagourney R; Fox P; Schein PS Cancer Res; 1977 Aug; 37(8 Pt 1):2615-8. PubMed ID: 141323 [No Abstract] [Full Text] [Related]